Home
Conditions
Thoracic Neoplasms

Clinical trial condition

Thoracic Neoplasms

Explore clinical trials studying Thoracic Neoplasms. Study availability and eligibility vary by location and protocol.

7,989 public trials 1,817 recruiting studies

Refine in advanced search Browse all conditions

Thoracic Neoplasms trial results

Active, Not Recruiting

A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

NCT05199272

Conditions: Adenocarcinoma, Adnexal Diseases, Bronchial Neoplasms, +45 more
Locations: Stanford Cancer Institute Palo Alto, California, United States

Emory University Atlanta, Georgia, United States

Karmanos Cancer Institute Detroit, Michigan, United States

R.J.Zuckerberg Cancer Center Lake Success, New York, United States

View all 13 locations

View Trial Details

Active, Not Recruiting

Almonertinib Versus Placebo as Adjuvant Therapy in Resected Stage II-IIIB Non-Small Cell Lung Cancer With EGFR-sensitive Mutations

NCT04687241

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Jilin Province Cancer Hospital Changchun, Jilin, China

View Trial Details

Active, Not Recruiting

Pembrolizumab Plus Lenvatinib In Second Line and Third Line Malignant Pleural mesotheLioma Patients

NCT04287829

Conditions: Adenoma, Lung Diseases, Lung Neoplasms, +12 more
Locations: Antoni van Leeuwenhoekziekenhuis (NKI-AVL) Amsterdam, North Holland, Netherlands

View Trial Details

Active, Not Recruiting

Activity of Lorlatinib Based on ALK Resistance Mutations Detected on Blood in ALK Positive NSCLC Patients

NCT04127110

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Institut Jules Bordet-Hopital Universitaire ULB Brussels, Belgium

Cliniques Universitaires Saint-Luc Brussels, Belgium

Universitair Ziekenhuis Antwerpen Edegem, Belgium

CHU-UCL Namur - CHU Mont Godinne - UCL Namur Yvoir, Belgium

View all 26 locations

View Trial Details

Active, Not Recruiting

A Phase 3, Controlled, Open-label, Global Randomized Study of RRx-001 With a Platinum Doublet or a Platinum Doublet in Small Cell Lung Cancer

NCT05566041

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Small Cell Lung, +8 more
Locations: H. Lee Moffitt Cancer Center & Research Institute, Inc. Tampa, Florida, United States

The University of Kansas Cancer Center Westwood, Kansas, United States

View Trial Details

Active, Not Recruiting

Study of Osimertinib + SRS vs Osimertinib Alone for Brain Metastases in EGFR Positive Patients With NSCLC

NCT03769103

Conditions: Brain Diseases, Brain Metastases, Brain Neoplasms, +15 more
Locations: BC Cancer, Vancouver Centre Vancouver, British Columbia, Canada

Princess Margaret Hospital Toronto, Ontario, Canada

Sunnybrook Health Sciences Centre Toronto, Ontario, Canada

View Trial Details

Active, Not Recruiting

LDCT Screening in Non-smokers in Taiwan

NCT02611570

Conditions: Behavior, Lung Cancer, Lung Diseases, +10 more
Locations: Chiayi Chang Gung Memorial Hospital Chiayi City, Taiwan

Hualien Tzu Chi Hospital Hualien City, Taiwan

Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung City, Taiwan

Kaohsiung Veterans General Hospital Kaohsiung City, Taiwan

View all 17 locations

View Trial Details

Active, Not Recruiting

Hippocampal Sparing Whole Brain Radiation Versus Stereotactic Radiation in Patients With 5-20 Brain Metastases: A Phase III, Randomized Trial

NCT03075072

Conditions: Adenocarcinoma, Brain Diseases, Brain Metastases, +40 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Active, Not Recruiting

Neoadjuvant PD-1 Inhibitor (Sintilimab), Anlotinib Combined With Chemotherapy in Resectable Stage IIA-IIIB NSCLC

NCT05400070

Conditions: Anlotinib, Chemotherapy, Lung Cancer, +8 more
Locations: Tangdu Hospital, the Air Force Military University Xi'an, China

View Trial Details

Active, Not Recruiting

Improving Utilization of Lung Cancer Screening in Underserved PA Populations

NCT04806399

Conditions: Lung Cancer, Lung Diseases, Lung Neoplasms, +5 more
Locations: Lehigh Valley Health Network Allentown, Pennsylvania, United States

Jefferson Health System Philadelphia, Pennsylvania, United States

View Trial Details

Thoracic Neoplasms

Thoracic Neoplasms trial results

Related conditions